[go: up one dir, main page]

GB0120808D0 - Crystalline material - Google Patents

Crystalline material

Info

Publication number
GB0120808D0
GB0120808D0 GBGB0120808.1A GB0120808A GB0120808D0 GB 0120808 D0 GB0120808 D0 GB 0120808D0 GB 0120808 A GB0120808 A GB 0120808A GB 0120808 D0 GB0120808 D0 GB 0120808D0
Authority
GB
United Kingdom
Prior art keywords
crystalline material
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0120808.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Pfizer Ltd Great Britain
Original Assignee
PFIZER Ltd
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd
Priority to GBGB0120808.1A priority Critical patent/GB0120808D0/en
Publication of GB0120808D0 publication Critical patent/GB0120808D0/en
Priority to JP2002235998A priority patent/JP2003128653A/en
Priority to EP02255716A priority patent/EP1287826A1/en
Priority to US10/224,663 priority patent/US6680334B2/en
Priority to CA002399567A priority patent/CA2399567A1/en
Priority to MXPA02008376A priority patent/MXPA02008376A/en
Priority to BR0203412-3A priority patent/BR0203412A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GBGB0120808.1A 2001-08-28 2001-08-28 Crystalline material Ceased GB0120808D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0120808.1A GB0120808D0 (en) 2001-08-28 2001-08-28 Crystalline material
JP2002235998A JP2003128653A (en) 2001-08-28 2002-08-13 Crystalline material
EP02255716A EP1287826A1 (en) 2001-08-28 2002-08-15 A crystalline form of the free base of Amlodipine
US10/224,663 US6680334B2 (en) 2001-08-28 2002-08-20 Crystalline material
CA002399567A CA2399567A1 (en) 2001-08-28 2002-08-23 Crystalline material
MXPA02008376A MXPA02008376A (en) 2001-08-28 2002-08-27 A crystalline form of the free base of amlodipine.
BR0203412-3A BR0203412A (en) 2001-08-28 2002-08-28 Crystalline material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0120808.1A GB0120808D0 (en) 2001-08-28 2001-08-28 Crystalline material

Publications (1)

Publication Number Publication Date
GB0120808D0 true GB0120808D0 (en) 2001-10-17

Family

ID=9921078

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0120808.1A Ceased GB0120808D0 (en) 2001-08-28 2001-08-28 Crystalline material

Country Status (6)

Country Link
EP (1) EP1287826A1 (en)
JP (1) JP2003128653A (en)
BR (1) BR0203412A (en)
CA (1) CA2399567A1 (en)
GB (1) GB0120808D0 (en)
MX (1) MXPA02008376A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
BE1014450A6 (en) * 2000-12-29 2003-10-07 Bioorg Bv New alkyl 2-(2-chlorobenzylidene)-4-(2-phthalimidoethoxy)-acetoacetates, useful as intermediates for the antianginal and antihypertensive agent amlodipine
BE1014922A3 (en) * 2002-03-01 2004-06-01 Pfizer Ltd Pharmaceutical composition useful for making amlodipine tablets, comprising amlodipine free base and excipients, leaves only a small residue in the tabletting press
AU2002368531A1 (en) * 2002-12-30 2004-07-22 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Isolation of dihydropyridine derivative and preparation salts thereof
WO2004075825A2 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Dosage forms of amlodipine and processes for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (en) * 1982-03-11 1991-12-09 Pfizer CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
GB0020842D0 (en) * 2000-08-23 2000-10-11 Pfizer Ltd Therapeutic compositions
DE20201878U1 (en) * 2002-02-07 2002-07-11 Bioorganics B.V., Nijmegen Free amlodipine base

Also Published As

Publication number Publication date
MXPA02008376A (en) 2003-03-05
EP1287826A1 (en) 2003-03-05
CA2399567A1 (en) 2003-02-28
BR0203412A (en) 2003-05-27
JP2003128653A (en) 2003-05-08

Similar Documents

Publication Publication Date Title
DE60233033D1 (en) Photochromsches material
IL161914A0 (en) Novel crystalline compound
IL153338A0 (en) Construction material
EP1405890A4 (en) Thermochromic material
EP1383143A4 (en) Solid material for magnet
GB0211754D0 (en) Surface material
GB0124812D0 (en) Material
AU2003297594A8 (en) Crystalline form
AU4298801A (en) Construction material
GB0210517D0 (en) Material
GB0125617D0 (en) Photostabilised organic material
HU0400176V0 (en) Improved gasketseal
GB0120808D0 (en) Crystalline material
GB0110091D0 (en) Nucleation-inducing material
GB0129273D0 (en) Crystalline drug form
GB0118255D0 (en) Absorbent material
GB0116005D0 (en) Packaging material
AU2002257961A1 (en) Fabric material
GB0119053D0 (en) Material
GB2376951B (en) Cleaning material
GB0106140D0 (en) Material
GB0228533D0 (en) Crystalline form
GB0108226D0 (en) Novel crystalline forms
GB0117620D0 (en) Fabrication material
HU0401770D0 (en) Material for external troobleshooting

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)